Why is Germany's CureVac vaccine just 48% effective? | Covid-19 Special DW News 11:52 3 years ago 40 796 Далее Скачать
CureVac is focusing on mRNA cancer vaccines, CFO says CNBC International News 2:45 2 years ago 747 Далее Скачать
CureVac CEO on the company's IPO and Covid-19 vaccine research CNBC Television 3:36 4 years ago 7 052 Далее Скачать
CureVac hopes to utilize innovations in mRNA to transform the medicines of today TBD Media Group 5:43 2 years ago 10 736 Далее Скачать
CureVac withdraws mRNA Covid vaccine application in Europe CNBC Television 2:53 3 years ago 2 736 Далее Скачать
mRNA will play a part in pandemic preparedness for the future, CureVac CEO says CNBC International News 5:19 3 years ago 442 Далее Скачать
Enough Pharma Capacity to Vaccinate World by End of 2021: CureVac CEO Bloomberg Television 5:15 4 years ago 2 097 Далее Скачать
CureVac CEO on IPO Pricing, Covid-19 Vaccine, Partners Bloomberg Television 6:17 4 years ago 3 319 Далее Скачать
Third mRNA COVID-19 vaccine CureVac on the cusp of announcing clinical trial results Arirang News 0:32 3 years ago 2 649 Далее Скачать
German Company CureVac is Rushing to Make a COVID-19 Vaccine | NowThis NowThis Impact 3:09 4 years ago 82 689 Далее Скачать
Germany's BioNTech, CureVac joins coronavirus vaccine race | COVID-19 | World News WION 2:33 4 years ago 5 726 Далее Скачать
47% efficacy: Did Germany's CureVac vaccine ultimately fail? | DW News DW News 4:18 3 years ago 44 524 Далее Скачать
CureVac to Release Results of Covid Vaccine Trials Bloomberg Television 4:09 3 years ago 8 220 Далее Скачать
COVID-19: GlaxoSmithKline, CureVac to develop vaccine against coronavirus variants CNA 3:38 3 years ago 3 758 Далее Скачать
Enough Pharma Capacity to Vaccinate World by End of 2021: CureVac CEO Bloomberg Quicktake 1:45 4 years ago 10 488 Далее Скачать
